Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

Vaccine

Volumn 14, Issue 12, 1996, Pages 1159-1166

  Hsu, Shiou Chih ^a   Schadeck, Eva B ^a   Delmas, Agnes ^a,b   Shaw, Michael ^a   Steward, Michael W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; ISCOM; MEASLES VACCINE; NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030581353     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00241-R     Document Type: Article

References (42)

1. 1 Yap, K.L. and Ada, G.L. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978, 273, 238
2. 2 Sethi, K.K., Ometa, Y. and Schnewis, K.W. Protection of mice from far herpes simplex virus type I infection by Adoptive transfer of cloned virus-specific and H-2 restricted cylotoxic T lymphocytes. J. Gen. Virol. 1983, 64, 443
3. 3 Achele, P., Hengartner, R., Zinkernagel, R.M. and Schulz, M. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 1990, 171, 1815
4. 4 Deres, K., Schild, H., Weismuler, K.-H., Jung, G. and Rammensee, H.-G. In vivo priming of virus specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989, 342, 561
5. + cytotoxic T-cell responses? A paradox revisited. Immunol. Today 1993, 14, 344
6. 6 Collins, D.S., Findlay, K. and Harding, C.V. Processing of erogenous liposome-encapsulated antigens in vivo generate class I MHC-restricted T cell responses. J. Immunol. 1992,148, 3336
7. + cytotoxic T lymphocyles toward soluble antigens. Eur. J. Immunol. 1991, 21, 1523
8. 8 Loygren, K., Lindmark, J., Pipkorn, R. and Morein, B. Antigenic presentation of small molecules and peptides conjugated to a performed ISCOM as carrier. J. Immunol. Meth. 1987, 98, 137
9. + cytotoxic T cells. Vaccine 1994, 12, 73
10. 10 Reid, G. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid. Vaccine 1992, 10, 597
11. 11 Pederson, Ir., Bog-Hansen, T.C., Dalsgaard, K. and Heegarrd, P.M. ISCOM immunization earth with synthetic peptides representing measles virus hemagglutinin. Virus Res. 1992, 24, 145
12. 12 Homma, M. and Ohuchi, M. Trypsin action on the growth of Sendai virus in tissue culture cells. J. Virol. 1973, 12, 1457
13. 13 Scheid, A. and Chopping, P.W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of inactive precursor protein of Sendai virus. Virology 1974, 57, 475
14. 14 Scheid, A., Graves, M., Silver, S. and Chopping, P.W. Mahy, B.W.J. Barry, R.D. Negative Strand Viruses and the Host Cell, 1978, 181-193. Academic Press, London
15. 15 Morrison, T.G. and Portner, A. Kingsbury, D.W. The Paramyxoviruses, 1991, 347-382. Plenum Press, New York
16. 16 Richardson, C.D. and Chopping, P.W. Oligopeptides that specifically inhibit membrane fusion by paramyoviruses: studies on the site of action. Virology 1983, 131, 518
17. 17 Richardson, C.D., Scheid, A. and Chopping, P.W. Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-terminus of the F1 or HA2 viral polypeptides. Virology 1980, 105, 205
18. 18 Paterson, R.G. and Lamb, R.A. Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor. Cell 1987, 48, 441
19. 19 Yeagle, P.L., Epand, R.M., Richardson, R.C. and Flanagan, T.D. Effects of the 'fusion peptide' from measles virus on the structure on N-methyl dioleoyl phosphatidylethanolamine membranes and their fusion with Sendai virus. Biochim. Biophys. Acta 1991, 1065, 49
20. 20 Novick, S.L. and Hoekstra, D. Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labelling. Proc. Natl Acad. Sci. USA 1988, 85, 7433
21. 21 Rapaport, D. and Shai, Y. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus earth phospholipid membranes. J. Biol. Chem. 1994, 269, 15124
22. 22 Horvath, C.M. and Lamb, R.A. Studies on the fusion peptide of a paramyxonus fusion glycoprotein: roles of conserved residues in cell fusion. J. Virol. 1922, 66, 2443
23. 23 Rodriguez-Crespo, I., Gomez-Gutierrez, J., Nieto, M., Peterson, D.L. and Gavilanes, F. Predicition of a putative fusion peptide in the S protein of hepatitis B virus. J. Gen. Virol. 1994, 75, 637
24. 24 Schadeck, E.B., Winkinson, G.W.G., Fooks, A.R. et al. Protective CTL epitopes from measles virus nucleocapsid protein identified following immunization with a defective recombinant adenovirus (submitted)
25. 25 Coligan, J.E., Kruisbeek, A.M., Marguiles, D.H., Shevach, E.M. and Strober, W. Preparation of immune stimulating complexes (ISCOMs) as adjuvant. In: Current Protocols in Immunology, Greene Publishing Associates & Wiley Interscience, 1992, p.2.11.1
26. 26 Fooks, A.R., Schadeck, E., Liebert, U.G. et al. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 1995, 210, 456
27. 27 Hanke, T., Graham, F.L., Rosenthal, K.L. and Jonson, D.C. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of Herpes Simplex Virus by using recombinant Adenovirus vectors and synthetic peptides. J. Virol. 1991, 65, 1177
28. 28 Shirai, M., Pendleton, C.D. and Berzofiky, J.A. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelop protein with multiple class I histocompatibility molecules. J. Immunol. 1992, 148, 1657
29. 29 Watson, D.L., Watson, N.A., Fossum, C., Lovgren, K. and Morein, B. Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes. Microbiol. Immunol. 1992, 36, 199
30. 30 Trudel, M., Nadon, F., Seguin, C., Brault, S., Lusignan, Y. and Lanieux, S. Initiation of cytotoxic T-cell response and protection of BALB/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Vaccine 1992, 10, 107
31. 31 Schild, H., Deres, K., Wiesmuller, K.-H., Jung, G. and Rammensee, H.-G. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur. J. Immunol. 1991, 21, 2649
32. 32 Martinson, F., Gras-Masses, H., Boutillon, C. et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. J. Immunol. 1992, 149, 3416
33. + cytotoxic T-cells in vivo by carrier-free HIV synthetic peptides. Proc. Natl Acad. Sci. USA 1991, 88, 9448
34. + T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res. 1994, 54, 4155
35. 35 Sweetser, M.T., Morrison, L.A., Braciale, V.L. and Braciale, T.J. Recognition of preprocessed endogenous antigen by class I but not class II MHC-restricted T cells. Nature 1989, 342, 180
36. 36 Gotch, F., Rothbard, J., Howland, K., Townsend, A. and McMichael, A. Cytotoxic T lymphocytes recognise a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987, 326, 881
37. 37 Moore, M.W., Carbone, F.R. and Bevan, M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988, 54, 777
38. 38 Pfeifer, J.D., Wick, M., Roberts, R.L., Findlay, K., Normark, S.J. and Harding, C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993, 361, 359
39. 39 Rock, K.L., Gamble, S. and Rothstein, L. Presentation of erogenous antigen with class I major histocompatibility complex molecules. Science 1990, 249, 918
40. 40 Reddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M. and Rouse, B.T. PH sensitive liposomes provide and efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J. Immunol. Meth. 1991, 141, 157
41. 41 Ulmer, J.B., Donnelly, J.J. and Liu, M.A. Presentation of an erogenous antigen by major histocompatibility complex class I molecules. Eur. J. Immunol. 1994, 24, 1590
42. 42 Kozlomski, S., Corr, M., Shirg, M. et al. Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides. J. Immunol. 1993, 151, 4033